Welcome to our dedicated page for NNMXD news (Ticker: NNMXD), a resource for investors and traders seeking the latest updates and insights on NNMXD stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect NNMXD's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of NNMXD's position in the market.
Nanomix Corporation (OTC: NNMX, NNMXD) has announced the appointment of Vidur Sahney as Chief Operating Officer. With over 20 years of experience, Mr. Sahney will oversee operations, including manufacturing and assay development. Additionally, the company has relocated its headquarters to a larger 9,325 square foot facility in San Leandro, California, which is 50% larger and half the cost of the previous site. These changes aim to enhance operational efficiency and support Nanomix's growth in point-of-care diagnostics.
Nanomix Corporation (OTC-PINK: NNMXD) has entered a $3 million securities purchase agreement with GHS Investments, LLC. This marks a significant transition for Nanomix from development to commercial operations. GHS, known for investing in promising small-cap companies, is expected to be a valuable partner. The agreement allows Nanomix to sell up to $3 million of common stock to GHS over several months. Nanomix specializes in mobile, point-of-care diagnostics, aiming to enhance healthcare delivery with rapid diagnostic solutions.
Nanomix Corporation (OTC-PINK: NNMXD, NNMX) will participate in the 2022 Virtual Growth Conference hosted by Maxim Group LLC from March 28-30, 2022. CEO David Ludvigson will present a company overview during the event. A pre-recorded presentation will be accessible for 72 hours from March 28, 9:00 a.m. ET, and an archived replay will be available on Nanomix's investor relations website.
FAQ
What is the market cap of NNMXD (NNMXD)?
